PharmGen Science, Inc. — Investor Relations & Filings
PharmGen Science, Inc. is a pharmaceutical company engaged in the research, development, production, and sale of medicaments. The company's portfolio encompasses a range of prescription (ETC) and over-the-counter (OTC) drugs, including analgesics, antibiotics, and anti-inflammatory agents. A key strategic focus for the company is the discovery and development of novel drugs for gastrointestinal (GI) disorders. PharmGen Science aims to provide integrated pharmaceutical solutions by leveraging its diverse infrastructure and global network.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]사업보고서 (2025.12) | 2026-05-15 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-05-12 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-12 | Korean | |
| 전환청구권ㆍ신주인수권ㆍ교환청구권행사 | 2026-05-12 | Welsh | |
| 최대주주등소유주식변동신고서 | 2026-05-12 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46368195 | [기재정정]사업보고서 (2025.12) | 2026-05-15 | Korean | ||
| 46367914 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 45154806 | 주식등의대량보유상황보고서(일반) | 2026-05-12 | Korean | ||
| 45154308 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-12 | Korean | ||
| 45142608 | 전환청구권ㆍ신주인수권ㆍ교환청구권행사 | 2026-05-12 | Welsh | ||
| 45142540 | 최대주주등소유주식변동신고서 | 2026-05-12 | Korean | ||
| 33119850 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33119832 | 대표이사(대표집행임원)변경(안내공시) | 2026-03-31 | Korean | ||
| 33119815 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-31 | Korean | ||
| 33013929 | [기재정정]주주총회소집공고 | 2026-03-23 | Korean | ||
| 33013880 | [기재정정]의결권대리행사권유참고서류 | 2026-03-23 | Korean | ||
| 33012270 | 감사보고서제출 | 2026-03-23 | Korean | ||
| 33012084 | 사업보고서 (2025.12) | 2026-03-23 | Korean | ||
| 32935565 | 주주총회소집공고 | 2026-03-12 | Korean | ||
| 32935494 | 의결권대리행사권유참고서류 | 2026-03-12 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
PharmGen Science, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17097/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17097 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17097 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17097 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17097}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmGen Science, Inc. (id: 17097)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.